Familial Hemophagocytic Lymphohistiocytosis Secondary to PRF1 Mutation

Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome that causes systemic inflammation which can progress to multiorgan failure and death. Symptoms and signs commonly seen in HLH include high fever, hepatosplenomegaly, pancytopenia, and hypertriglyceridemia. This...

Full description

Bibliographic Details
Main Authors: Albaraa T. Alfaraidi, Abdulaziz A. Alqarni, Mohammed T. Aqeel, Turki A. Albalawi, Ahmed S. Hejazi
Format: Article
Language:English
Published: Hindawi Limited 2021-01-01
Series:Case Reports in Hematology
Online Access:http://dx.doi.org/10.1155/2021/7213939
_version_ 1798034325871001600
author Albaraa T. Alfaraidi
Abdulaziz A. Alqarni
Mohammed T. Aqeel
Turki A. Albalawi
Ahmed S. Hejazi
author_facet Albaraa T. Alfaraidi
Abdulaziz A. Alqarni
Mohammed T. Aqeel
Turki A. Albalawi
Ahmed S. Hejazi
author_sort Albaraa T. Alfaraidi
collection DOAJ
description Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome that causes systemic inflammation which can progress to multiorgan failure and death. Symptoms and signs commonly seen in HLH include high fever, hepatosplenomegaly, pancytopenia, and hypertriglyceridemia. This report describes the 8-month clinical course of a 17-year-old male with G6PD deficiency who presented with intermittent high fever of unknown origin for 8 months accompanied by pancytopenia and bilateral lower limb weakness. A pathogenic homozygous missense mutation (c.1081A > T p.(Arg361Trp)) in the PRF1 gene was detected by whole exome sequencing (WES). The brain and the whole spine MRI showed leptomeningeal enhancement at different levels involving both the brain and the spine. Therefore, a diagnosis of familial HLH type 2 with CNS involvement was confirmed. Accordingly, treatment with dexamethasone, cyclosporin, and etoposide in addition to intrathecal methotrexate and hydrocortisone was given. The patient showed a dramatic response with significant neurological improvement of the bilateral lower limb weakness. Genetic analysis has helped the patient’s family with appropriate genetic counselling. This case highlights the importance of immediate treatment with immunosuppressants and the high clinical suspicion of physicians regarding HLH in areas where consanguinity is common.
first_indexed 2024-04-11T20:42:39Z
format Article
id doaj.art-851356e0724d4b17b9af2856cef02687
institution Directory Open Access Journal
issn 2090-6579
language English
last_indexed 2024-04-11T20:42:39Z
publishDate 2021-01-01
publisher Hindawi Limited
record_format Article
series Case Reports in Hematology
spelling doaj.art-851356e0724d4b17b9af2856cef026872022-12-22T04:04:09ZengHindawi LimitedCase Reports in Hematology2090-65792021-01-01202110.1155/2021/7213939Familial Hemophagocytic Lymphohistiocytosis Secondary to PRF1 MutationAlbaraa T. Alfaraidi0Abdulaziz A. Alqarni1Mohammed T. Aqeel2Turki A. Albalawi3Ahmed S. Hejazi4College of MedicineCollege of MedicineCollege of MedicineCollege of MedicineDepartment of OncologyHemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome that causes systemic inflammation which can progress to multiorgan failure and death. Symptoms and signs commonly seen in HLH include high fever, hepatosplenomegaly, pancytopenia, and hypertriglyceridemia. This report describes the 8-month clinical course of a 17-year-old male with G6PD deficiency who presented with intermittent high fever of unknown origin for 8 months accompanied by pancytopenia and bilateral lower limb weakness. A pathogenic homozygous missense mutation (c.1081A > T p.(Arg361Trp)) in the PRF1 gene was detected by whole exome sequencing (WES). The brain and the whole spine MRI showed leptomeningeal enhancement at different levels involving both the brain and the spine. Therefore, a diagnosis of familial HLH type 2 with CNS involvement was confirmed. Accordingly, treatment with dexamethasone, cyclosporin, and etoposide in addition to intrathecal methotrexate and hydrocortisone was given. The patient showed a dramatic response with significant neurological improvement of the bilateral lower limb weakness. Genetic analysis has helped the patient’s family with appropriate genetic counselling. This case highlights the importance of immediate treatment with immunosuppressants and the high clinical suspicion of physicians regarding HLH in areas where consanguinity is common.http://dx.doi.org/10.1155/2021/7213939
spellingShingle Albaraa T. Alfaraidi
Abdulaziz A. Alqarni
Mohammed T. Aqeel
Turki A. Albalawi
Ahmed S. Hejazi
Familial Hemophagocytic Lymphohistiocytosis Secondary to PRF1 Mutation
Case Reports in Hematology
title Familial Hemophagocytic Lymphohistiocytosis Secondary to PRF1 Mutation
title_full Familial Hemophagocytic Lymphohistiocytosis Secondary to PRF1 Mutation
title_fullStr Familial Hemophagocytic Lymphohistiocytosis Secondary to PRF1 Mutation
title_full_unstemmed Familial Hemophagocytic Lymphohistiocytosis Secondary to PRF1 Mutation
title_short Familial Hemophagocytic Lymphohistiocytosis Secondary to PRF1 Mutation
title_sort familial hemophagocytic lymphohistiocytosis secondary to prf1 mutation
url http://dx.doi.org/10.1155/2021/7213939
work_keys_str_mv AT albaraatalfaraidi familialhemophagocyticlymphohistiocytosissecondarytoprf1mutation
AT abdulazizaalqarni familialhemophagocyticlymphohistiocytosissecondarytoprf1mutation
AT mohammedtaqeel familialhemophagocyticlymphohistiocytosissecondarytoprf1mutation
AT turkiaalbalawi familialhemophagocyticlymphohistiocytosissecondarytoprf1mutation
AT ahmedshejazi familialhemophagocyticlymphohistiocytosissecondarytoprf1mutation